Statin treatment and functional outcome after ischemic stroke: Case-control and meta-analysis

Stroke

Volumn 42, Issue 5, 2011, Pages 1314-1319

  Biffi, Alessandro ^a   Devan, William J ^a   Anderson, Christopher D ^a   Cortellini, Lynelle ^a   Furie, Karen L ^a   Rosand, Jonathan ^a   Rost, Natalia S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

acute stroke; cerebral infarct; functional recovery; meta analysis; outcomes; statins; stroke recovery

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

AGED; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PROGNOSIS; STROKE; TREATMENT OUTCOME;

EID: 79955465542     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.605923     Document Type: Article

References (23)

1. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8: 355-369.
2. American Heart Association Statistics Committee and Stroke Statistics Sub-committee. Executive summary: heart disease and stroke statistics\2010 update: a report from the American Heart Association. Circulation. 2010; 121:948-954.
3. Miida T, Takahashi A, Ikeuchi T. Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects. Pharmacol Ther. 2007;113:378-393. (Pubitemid 46149052)
4. Vaughan CJ. Prevention of stroke and dementia with statins: effects beyond lipid lowering. Am J Cardiol. 2003;91:23B-29B. (Pubitemid 36263245)
5. Reeves MJ, Gargano JW, Luo Z, Mullard AJ, Jacobs BS, Majid A. Paul Coverdell National Acute Stroke Registry Michigan Prototype Investi-gators. Effect of pretreatment with statins on ischemic stroke outcomes. Stroke. 2008;39:1779-1785.
6. Greisenegger S, Müllner M, Tentschert S, Lang W, Lalouschek W. Effect of pretreatment with statins on the severity of acute ischemic cerebro-vascular events. J Neurol Sci. 2004;221:5-10. (Pubitemid 38721284)
7. Yu AY, Keezer MR, Zhu B, Wolfson C, Côté R. Pre-stroke use of antihypertensives, antiplatelets, or statins and early ischemic stroke outcomes. Cerebrovasc Dis. 2009;27:398-402.
8. Yoon SS, Dambrosia J, Chalela J, Ezzeddine M, Warach S, Haymore J, Davis L, Baird AE. Rising statin use and effect on ischemic stroke outcome. BMC Med. 2004;2:4.
9. Arboix A, García-Eroles L, Oliveres M, Targa C, Balcells M, Massons J. Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect ofhypercholesterolemia? BMC Neurol. 2010;10:47.
10. Martí-Fàbregas J, Gomis M, Arboix A, Aleu A, Pagonabarraga J, Belvís R, Cocho D, Roquer J, Rodríguez A, García MD, Molina-Porcel L, Díaz-Manera J, Martí-Vilalta JL. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke. 2004;35:1117-1121.
11. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke. 2005;36:1298-1300. (Pubitemid 40798758)
12. Elkind MS, Flint AC, Sciacca RR, Sacco RL. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology. 2005;65:253-258. (Pubitemid 41022370)
13. Jonsson N, Asplund K. Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study. Stroke. 2001;32: 1112-1115. (Pubitemid 32825793)
14. Martínez-Sánchez P, Rivera-Ordóñez C, Fuentes B, Ortega-Casarrubios MA, Idrovo L, Díez-Tejedor E. The beneficial effect of statins treatment by stroke subtype. Eur J Neurol. 2009;16:127-133.
15. Goldstein LB, Amarenco P, Zivin J, Messig M, Altafullah I, Callahan A, Hennerici M, MacLeod MJ, Sillesen H, Zweifler R, Michael K, Welch A; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Inves-tigators. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2009;40:3526-3531.
16. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke. Defi-nitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41. (Pubitemid 23014379)
17. Jimenez-Conde J, Biffi A, Rahman R, Kanakis A, Butler C, Sonni S, Massasa E, Cloonan L, Gilson A, Capozzo K, Cortellini L, Ois A, Cuadrado-Godia E, Rodriguez-Campello A, Furie KL, Roquer J, Rosand J, Rost NS. Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke. 2010;41:437-442.
18. Ay H, Arsava EM, Vangel M, Oner B, Zhu M, Wu O, Singhal A, Koroshetz WJ, Sorensen AG. Interexaminer difference in infarct volume measurements on MRI: a source of variance in stroke research. Stroke. 2008;39:1171-1176. (Pubitemid 351440687)
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 1986;7:177-188. (Pubitemid 17189972)
20. Ioannidis JP. Interpretation of tests of heterogeneity and bias in meta-analysis. J Eval Clin Pract. 2008;14:951-957.
21. Sutton AJ, Jones DR, Abrams KR, Sheldon TA, Song F. Publication bias. In: Sutton AJ, Jones DR, Abrams KR, Sheldon TA, Song F, eds. Methods for Meta-Analysis in Medical Research. IEd. Chichester, UK: John Wiley & Sons; 2000:109-132.
22. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Stat Med. 2007;26:4544-4562. (Pubitemid 350020393)
23. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010; 9:689-701